MEDP

Medpace Holdings, Inc.

Halal Rating :
Comfortable
Last Price $337.34 Last updated:
Market Cap $11.01b
7D Change -4.17%
1 Year Change 12.53%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Services
  • Business Services
  • Services – Research
  • Development
  • Testing Labs
Exchange NASDAQ
Next Earnings Date Oct. 21, 2024

Medpace Holdings, Inc. is a clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company helps clients in the design and execution of clinical trials, regulatory submissions, and various laboratory testing services to support drug and medical device development.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $533.32m $421.04m - - 0.00% 0.00%
June 30, 2024 $528.1m $422.95m - - 0.00% 0.00%
March 31, 2024 $511.04m $406.98m - - 0.00% 0.00%

Company Impact

Help us evaluate Medpace Holdings, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates